We are live on
!
Find out more
ACM
Ayer Capital Management Portfolio holdings
AUM
$26.8M
This Fund
S&P 500
This Quarter
Est. Return
-18.92%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$26.8M
AUM Growth
-$41.4M
(-61%)
Cap. Flow
-$31M
Cap. Flow
% of AUM
-115.7%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Iovance Biotherapeutics
IOVA
|
+$31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
OHCM
AC
IT
WA
MCM
ADICC
SC
3NC
Ayer Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Ayer Capital Management held 2 positions worth $26.8M, down 61% from $68.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Ayer Capital Management withdrew a net $31M in Q2 2015, reducing 1 holding. Its largest reduction was Iovance Biotherapeutics, cutting an estimated $31M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Ayer Capital Management's biggest Q2 2015 reduction was Iovance Biotherapeutics, cutting an estimated $31M.
- Ayer Capital Management's ten largest holdings make up 100% of its $26.8M portfolio in Q2 2015.
- Ayer Capital Management opened 0 new positions and closed 0 in Q2 2015.
- Ayer Capital Management's portfolio value fell 61% quarter-over-quarter to $26.8M.
Based on Ayer Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.